Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-06 Sale | 2024-03-08 5:33 pm | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 119,323 | $30.64 | $3,656,226 | 22,127 (Direct) | View |
| 2023-12-19 Purchase | 2023-12-19 6:39 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 30,000 | $1.37 | $41,100 | 697,761 (Direct) | View |
| 2023-11-10 Purchase | 2023-11-14 4:24 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 22,950 | $0.98 | $22,491 | 667,761 (Direct) | View |
| 2023-05-11 Sale | 2023-05-15 6:53 pm | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 5,015 | $41.78 | $209,527 | 139,675 (Direct) | View |
| 2022-09-15 Purchase | 2022-09-19 08:37 am | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 150,000 | $1.71 | $256,500 | 644,811 (Direct) | View |
| 2022-02-28 Sale | 2022-03-01 6:03 pm | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 30,000 | $66.87 | $2,006,150 | 130,889 (Direct) | View |
| 2021-09-21 Purchase | 2021-09-22 5:54 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 30,000 | $6.75 | $202,500 | 494,811 (Direct) | View |
| 2021-03-23 Purchase | 2021-03-24 10:27 am | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 10,000 | $10.23 | $102,300 | 464,811 (Direct) | View |
| 2021-03-18 Purchase | 2021-03-19 11:34 am | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 3,000 | $10.55 | $31,660 | 454,811 (Direct) | View |
| 2021-03-04 Purchase | 2021-03-04 8:46 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 1,500 | $9.265 | $13,898 | 451,811 (Direct) | View |
| 2020-09-16 Purchase | 2020-09-17 09:42 am | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 2,550 | $5.6967 | $14,527 | 450,311 (Direct) | View |
| 2020-05-11 Purchase | 2020-05-13 4:16 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 447,761 | $1.34 | $600,000 | 447,761 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-27 Option Award | 2024-07-01 4:09 pm | 2025-06-27 2034-06-27 | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 29,700 | $0 | 146,974 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:04 pm | 2024-06-15 2033-06-15 | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 27,700 | $0 | 117,274 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:36 pm | 2024-06-14 2033-06-14 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 14,700 | $0 | 154,375 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-15 6:53 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 7,000 | $29.9 | 139,675 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-15 6:53 pm | N/A 2023-06-12 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 7,000 | $0 | 139,675 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-08 7:37 pm | 2023-06-08 2032-06-08 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 9,385 | $0 | 145,915 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 2:11 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 26,800 | $0 | 89,574 (Direct) | View |
| 2022-03-03 Exercise | 2022-03-07 8:07 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 7,000 | $10.81 | 136,530 (Direct) | View |
| 2022-03-03 Exercise | 2022-03-07 8:07 pm | N/A 2022-06-04 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 7,000 | $0 | 136,530 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-01 6:03 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 30,000 | $11.02 | 130,889 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-01 6:03 pm | N/A 2022-04-02 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 30,000 | $0 | 130,889 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:13 pm | 2022-06-10 2031-06-10 | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 22,000 | $0 | 62,774 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 8:47 pm | 2022-06-09 2031-06-09 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 8,692 | $0 | 137,156 (Direct) | View |
| 2021-05-13 Gift | 2021-06-11 8:47 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 1,485 | $0 | 137,156 (Direct) | View |
| 2020-09-25 Exercise | 2020-09-29 5:16 pm | N/A 2022-08-16 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 70,000 | $0 | 129,949 (Direct) | View |
| 2020-09-25 Exercise | 2020-09-29 5:16 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 70,000 | $16.67 | 129,949 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:17 pm | 2021-06-17 2030-06-17 | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 28,858 | $0 | 40,774 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 6:27 pm | 2021-06-09 2030-06-09 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 9,287 | $0 | 67,976 (Direct) | View |
| 2020-04-16 Option Award | 2020-05-01 4:17 pm | N/A 2030-04-16 | Trovagene Inc. | TROV | PACE GARY W Director | 11,916 | $0 | 11,916 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-16 5:54 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 5,000 | $13.98 | 58,689 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-16 5:54 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 12,087 | $1.61 | 58,689 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-16 5:54 pm | N/A 2020-09-02 | Pacira BioSciences Inc. | PCRX | PACE GARY W Director | 21,736 | $0 | 58,689 (Direct) | View |